DPP-4 inhibitors work by blocking an enzyme that breaks down incretin hormones, including GLP-1
Tirzepatide demonstrates significant extrahepatic benefits beyond its well-established hepatic effects, particularly in the cardiovascular and metabolic domains
Individual results vary depending on factors such as lifestyle, diet, and unique body chemistry
But one question comes up again and again: stop GLP-1 medications without gaining the weight back The short answer is yes, some people can maintain their weight loss after stopping GLP-1 medications
We currently have a randomised, placebo-controlled human clinical study in progress for the product
Early promise The GLP-1 hormone is part of the intricate mechanism in our bodies to distribute glucose, but avoid the toxicity associated with high concentrations in the bloodstream